mPEG9-amine

 CAS No.: 211859-73-3  Cat No.: BP-501038  Purity: ≥95% 4.5  

mPEG9-amine is a mono-functional amine-terminated PEG linker designed to increase solubility and circulation half-life of ADCs. It is ideal for bioconjugation applications requiring hydrophilic, flexible spacers in antibody-drug conjugates or protein-polymer conjugates.

mPEG9-amine

Structure of 211859-73-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
PROTAC Linker
Molecular Formula
C19H41NO9
Molecular Weight
427.53
Appearance
Pale Yellow Oily Liquid

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • mg to g scale for early stage;
  • CDMO and CMO support.
  • 24/7 customer service;
  • 100% quality assurance;
  • Efficient global delivery;
  • Over 95% customer satisfaction.
Popular Publications Citing BOC Sciences Products
Purity
≥95%
Solubility
Soluble in DMSO (10 mm)
Appearance
Pale Yellow Oily Liquid
ShelfLife
≥ 2 years
Storage
Store at 2-8°C
Shipping
Room temperature, or blue ice upon request.
IUPACName
2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanamine
Synonyms
m-PEG9-amine; 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-amine; MPEG9-NH2; Methyl-PEG9-amine
Boiling Point
484.3±40.0 °C at 760 mmHg
Density
1.060±0.06 g/cm3 (Predicted)
InChI Key
FYQAZBUDEOSOFG-UHFFFAOYSA-N
InChI
InChI=1S/C19H41NO9/c1-21-4-5-23-8-9-25-12-13-27-16-17-29-19-18-28-15-14-26-11-10-24-7-6-22-3-2-20/h2-20H2,1H3
Canonical SMILES
COCCOCCOCCOCCOCCOCCOCCOCCOCCN
Biological Activity
m-PEG9-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1] . In Vitro: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
1.HDL functionality in South Asians as compared to white Caucasians.
Bakker LE1, Boon MR2, Annema W3, Dikkers A4, van Eyk HJ1, Verhoeven A5, Mayboroda OA5, Jukema JW6, Havekes LM7, Meinders AE1, Willems van Dijk K8, Jazet IM1, Tietge UJ3, Rensen PC9. Nutr Metab Cardiovasc Dis. 2016 Feb 19. pii: S0939-4753(15)30087-9. doi: 10.1016/j.numecd.2016.02.010. [Epub ahead of print]
BACKGROUND AND AIMS: South Asians have an exceptionally high risk of developing cardiovascular disease compared to white Caucasians. A contributing factor might be dysfunction of high density lipoprotein (HDL). We aimed to compare HDL function in different age groups of both ethnicities.
2.[Treatment of the old terrible triad of the elbow without operative history].
Zha YJ1, Jiang XY1, Gong MQ1. Beijing Da Xue Xue Bao. 2016 Apr 18;48(2):224-9.
OBJECTIVE: To introduce the surgical techniques and treating results of the old "terrible triad" of the elbow.
3.Impact of a systems engineering intervention on PMTCT service delivery in Côte d'Ivoire, Kenya, Mozambique: a cluster randomized trial.
Rustagi AS1, Gimbel S, Nduati R, Cuembelo MF, Wasserheit JN, Farquhar C, Gloyd S, Sherr K; with input from the SAIA Study Team. J Acquir Immune Defic Syndr. 2016 Apr 14. [Epub ahead of print]
BACKGROUND: Efficacious interventions to prevent mother-to-child HIV transmission (PMTCT) have not translated well into effective programs. Prior studies of systems engineering applications to PMTCT lacked comparison groups or randomization.
4.Comparison of mid-term haemodynamic performance between the BioValsalva and the BioIntegral valved conduits after aortic root replacement.
Wendt D1, Raweh A2, Knipp S2, El Gabry M2, Eißmann M3, Dohle DS2, Tsagakis K2, Thielmann M2, Jakob H2, Benedik J2. Interact Cardiovasc Thorac Surg. 2016 Apr 4. pii: ivw066. [Epub ahead of print]
OBJECTIVES: We retrospectively compared the haemodynamic performance of the BioValsalva (BV) and BioIntegral (BI) biological aortic-valved conduits in the aortic root position.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
Germany
Inquiry Basket